Case report: A case of duodenal adenocarcinoma achieving significantly long survival treating with immune checkpoint inhibitors and chemotherapy without positive biomarkers

Small bowel adenocarcinoma (SBA), particularly duodenal adenocarcinoma (DA), is a rare gastrointestinal cancer with a dismal prognosis. Data on SBA treatments are limited, and the therapeutic strategy remains uncertain. Currently, chemotherapy is the most used treatment; however, it has a poor media...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xian, Zhou, Rui, Li, Yong, Qu, Xin, Qu, Yan-chun, Li, Wen-zhu, Ye, Yong-song, Liu, Li-rong, Zhu, Yan-juan, Zhang, Hai-bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755197/
https://www.ncbi.nlm.nih.gov/pubmed/36531985
http://dx.doi.org/10.3389/fimmu.2022.1046513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755197/
https://www.ncbi.nlm.nih.gov/pubmed/36531985
http://dx.doi.org/10.3389/fimmu.2022.1046513

Ejemplares similares